Lenalidomid-Teva 25 mg, Hartkapseln - 21 Swissmedic Key 67460007 Registration Holder Teva Pharma AG Name Lenalidomid-Teva 25 mg, Hartkapseln Date of registration 05.11.2019 Original/Generic Generic Introduction of Sequence 05.11.2019 ATC-Classification Lenalidomide (L04AX04) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.16.10. Show package size 21 Index Therapeuticus (Swissmedic) 07.16.40. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 861.14 Limitation Yes Limitation text
Deductible 10 % Consumer price 952.95 Feedback FB Daily cost GTIN 7680674600077 Medication Code Synthetika Pharmacode Disponibility
Composition lenalidomidum 25 mg ut lenalidomidi hydrochloridum monohydricum, silica colloidalis anhydrica, cellulosum microcristallinum carmellosum natricum conexum corresp. natrium 0.06 mg, talcum, Kapselhülle: gelatina, E 171, Drucktinte: lacca, propylenglycolum, ammoniae solutio 30 per centum, E 172 (nigrum), kalii hydroxidum, pro capsula. Packungsbestandteile Galenic Form Capsules Active Agent Dose Lenalidomidum 25 mg
BAG: Active Agent Dose Lenalidomidum 25 mg
Inactive agents Dose additional_information (Nigrum) Ammoniae Solutio 30 Cellulosum Microcristallinum Carmellosum Natricum Conexum E 171 color. E 172 color. Gelatina Kapselhülle Kalii Hydroxidum Lacca Drucktinte Per Centum Pro Capsula Propylenglycol Silica Colloidalis Anhydrica Talcum
Source Data was imported : 04.04.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
